BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 1438717)

  • 1. [Bone marrow scintigraphy. Principles, clinical results and indications].
    Munz DL
    Radiologe; 1992 Oct; 32(10):485-94. PubMed ID: 1438717
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 99Tcm-LL1: a potential new bone marrow imaging agent.
    Juweid M; Dunn RM; Sharkey RM; Rubin AD; Hansen HJ; Goldenberg DM
    Nucl Med Commun; 1997 Feb; 18(2):142-8. PubMed ID: 9076770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Detection of bone marrow involvement in breast cancer and malignant lymphoma using immunoscintigraphy of the hematopoietic bone marrow].
    Reske SN; Karstens JH; Glöckner WM; Ammon J; Büll U
    Rofo; 1990 Jan; 152(1):60-6. PubMed ID: 2154012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone marrow immunoscintigraphy using technetium-99m anti-granulocyte antibody in multiple myeloma.
    Sohn SK; Ahn BC; Lee SW; Kim DH; Chun KA; Kim JG; Park SH; Song HS; Lee B; Lee J
    Eur J Nucl Med Mol Imaging; 2002 May; 29(5):591-6. PubMed ID: 11976796
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radioimmunoimaging for diagnosis of bone marrow involvement in breast cancer and malignant lymphoma.
    Reske SN; Karstens JH; Gloeckner W; Steinsträsser A; Schwarz A; Ammon J; Buell U
    Lancet; 1989 Feb; 1(8633):299-301. PubMed ID: 2563458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunoscintigraphy of the bone marrow: normal uptake values of technetium-99m-labeled monoclonal antigranulocyte antibodies.
    Huić D; Ivancević V; Richter WS; Munz DL
    J Nucl Med; 1997 Nov; 38(11):1755-8. PubMed ID: 9374347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone marrow scintigraphy with 99m Tc labelled monoclonal anti-NCA 90 Fab' fragment: a feasibility study and comparison of bone marrow uptake with 99m Tc labelled monoclonal anti-NCA 95 antigranulocyte antibody.
    Ivancevic V; Huic D; Wolter A; Munz DL
    Nucl Med Commun; 2002 Mar; 23(3):249-55. PubMed ID: 11891483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bone marrow scintigraphy using technetium-99m antigranulocyte antibody in malignant lymphomas.
    Krause T; Eisenmann N; Reinhardt M; Bathmann J; Altehoefer C; Finke J; Moser E
    Ann Oncol; 1999 Jan; 10(1):79-85. PubMed ID: 10076726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The value of bone marrow scintigraphy and magnetic resonance tomography in diagnostic imaging of bone marrow].
    Bathmann J; Sigmund G
    Aktuelle Radiol; 1994 Jul; 4(4):159-68. PubMed ID: 7918703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bone marrow scintigraphy in multiple myeloma. A comparison with bone scintigraphy and skeletal radiology].
    Feggi LM; Spanedda R; Scutellari PN; Prandini N; Gennari M; Orzincolo C; Scapoli GL; Bagni B
    Radiol Med; 1988 Oct; 76(4):311-5. PubMed ID: 3141987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Technetium-99m monoclonal antibody fragment (Fab) scintigraphy in the evaluation of small cell lung cancer: a preliminary report.
    Morris JF; Krishnamurthy S; Antonovic R; Duncan C; Turner FE; Krishnamurthy GT
    Int J Rad Appl Instrum B; 1991; 18(6):613-20. PubMed ID: 1660451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of reticuloendothelial scans with bone scans in malignant disease.
    Shreiner DP; Hsu Y
    Clin Nucl Med; 1981 Mar; 6(3):101-4. PubMed ID: 7460451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoscintigraphy of bone marrow in plasmacytoma].
    Bathmann J; Brugger W; Ullrich C; Mertelsmann R; Moser E
    Nuklearmedizin; 1995 Apr; 34(2):66-70. PubMed ID: 7761276
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow uptake of 99mTc-MIBI in patients with multiple myeloma.
    Blocklet D; Schoutens A; Kentos A; Feremans W
    Eur J Nucl Med; 2001 Sep; 28(9):1430-2. PubMed ID: 11585304
    [No Abstract]   [Full Text] [Related]  

  • 15. Radionuclides in oncology.
    Jones SE
    Ric Clin Lab; 1977; 7(2):143-59. PubMed ID: 72399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of bone marrow immunoscintigraphy using a Tc-99m labeled anti-NCA-95 monoclonal antibody.
    Choi CW; Chung JK; Lee DS; Lee MC; Chung HK; Kim BK; Koh CS
    Nucl Med Biol; 1995 Jan; 22(1):117-23. PubMed ID: 7735161
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone marrow immunoscintigraphy compared with conventional bone scintigraphy for the detection of bone metastases.
    Reske S; Kartsens J; Sohn M; Glöckner W; Buell U
    Acta Oncol; 1993; 32(7-8):753-61. PubMed ID: 8305223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disseminated bone marrow metastases from primary breast cancer: detection and follow-up by radioimmune bone marrow scintigraphy.
    Rieker O; Grünwald F; Layer G; Kurbacher CM; Hotze AL; Menzel C; Biersack HJ
    J Nucl Med; 1994 Sep; 35(9):1485-7. PubMed ID: 8071697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone marrow scintigraphy with technetium-99m anti-NCA-95 to monitor therapy in malignant osteopetrosis.
    Thelen MH; Eschmann SM; Moll-Kotowski M; Dopfer R; Bares R
    J Nucl Med; 1998 Jun; 39(6):1033-5. PubMed ID: 9627340
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in bone marrow scanning.
    Reske SN
    Eur J Nucl Med; 1991; 18(3):203-21. PubMed ID: 2040342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.